ANI Pharmaceuticals Inc (ANIP): Net Income
$78.34M
Year ended 2025-12-31
$108.31M
Trailing 12 months to 2026-06-30
+17.7%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $78.34M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | -$18.52M | n/m | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $18.78M | n/m | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | -$47.90M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$42.60M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$22.55M | n/m | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $6.09M | -60.7% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $15.49M | n/m | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | -$1.08M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $3.93M | -74.4% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $15.38M | -46.5% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $28.75M | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $301.0K | n/m | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | -$1.51M | n/a | 2014-02-28, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $78.34M | n/m |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $158.69M | +9.1% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $30.11M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$381.39M | n/m |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$288.28M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $62.87M | -9.1% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $99.65M | -29.4% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $52.60M | n/m |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $391.00M | +72.7% |
Compare ANIP, HRMY, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗